Elevated Plasma Surfactant Protein D (SP‐D) Levels and a Direct Correlation with Anti‐severe Acute Respiratory Syndrome Coronavirus‐specific IgG Antibody in SARS Patients

Autor: N Y Mao, Zuo Li Xia, Kenneth B.M. Reid, P. G. De Groot, W B Xu, Uffe Holmskov, Shao Dong Pan, Zhihua Liu, Ya Ping Wu, Grith Lykke Sørensen, Ran Wei, F S Zhang, Ji Ju Han, Biao Chen
Jazyk: angličtina
Rok vydání: 2009
Předmět:
Zdroj: Scandinavian Journal of Immunology
Wu, Y P, Liu, Z H, Wei, R, Pan, S D, Mao, N Y, Chen, B, Han, J J, Zhang, F S, Holmskov, U, Xia, Z L, de Groot, P G, Reid, K B M, Xu, W B & Sørensen, G L 2009, ' Elevated plasma surfactant protein D (SP-D) levels and a direct correlation with anti-severe acute respiratory syndrome coronavirus-specific IgG antibody in SARS patients ', Scandinavian Journal of Immunology, vol. 69, no. 6, pp. 508-15 . https://doi.org/10.1111/j.1365-3083.2009.02245.x
ISSN: 1365-3083
0300-9475
DOI: 10.1111/j.1365-3083.2009.02245.x
Popis: Pulmonary SP‐D is a defence lectin promoting clearance of viral infections. SP‐D is recognized to bind the S protein of SARS‐CoV and enhance phagocytosis. Moreover, systemic SP‐D is widely used as a biomarker of alveolar integrity. We investigated the relation between plasma SP‐D, SARS‐type pneumonia and the SARS‐specific IgG response. Sixteen patients with SARS, 19 patients with community‐acquired pneumonia (CAP) (Streptococcus pneumonia) and 16 healthy control subjects were enrolled in the study. Plasma SP‐D and anti‐SARS‐CoV N protein IgG were measured using ELISA. SP‐D was significantly elevated in SARS‐type pneumonia [median (95% CI), 453 (379–963) ng/ml versus controls 218 (160–362) ng/ml, P
Databáze: OpenAIRE